Barry J. Simon, Director at ImmunityBio, Inc. (IBRX), sold 250,000 shares at $16.09 ($4.0M) on 2021-05-21, disclosed to the SEC on 2021-05-25.
Open-market sale of $4.0M IBRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.09 | 14,990 | $241K | 6.0% |
| 2 | $16.09 | 14,990 | $241K | 6.0% |
| 3 | $16.02 | 21,223 | $340K | 8.4% |
| 4 | $16.02 | 21,223 | $340K | 8.4% |
| 5 | $16.18 | 88,787 | $1.4M | 35.6% |
| 6 | $16.18 | 88,787 |
| $1.4M |
| 35.6% |
| Total | $16.14 avg | 250,000 | $4.0M | 100% |
| Filing → |
| IBRX | SELL | 2026-06-05 | $165K | — | Filing → |
| IBRX | SELL | 2026-02-26 | $1.8M | — | Filing → |
| IBRX | SELL | 2026-02-24 | $3.5M | — | Filing → |